Archana Asundi MD
Research Assistant Professor, Infectious Diseases
650 Albany St | (617) 414-5260
Dr. Archana Asundi obtained her undergraduate degree from Tufts University and her medical degree from McGill University in Montreal, Canada. She then completed her internal medicine residency training at the Jewish General Hospital, as part of the McGill University Internal Medicine training program. Her areas of interest include tropical medicine and immigrant and refugee health.
MD, McGill University, 2013
Psychology, BA, Tufts University, 2006
Asundi A, O'Leary C, Bhadelia N. Global COVID-19 vaccine inequity: The scope, the impact, and the challenges. Cell Host Microbe. 2021 07 14; 29(7):1036-1039. PMID: 34265241.Published on 4/7/2021
Asundi A, Resnik J, Benedict PA, Shin M, Rani Elwy A, Branch-Elliman W. How Are Emerging Data Translated Into Clinical Practice? A Mixed Methods Investigation of Coronavirus Disease 2019 Institutional Treatment Protocols. Open Forum Infect Dis. 2021 Apr; 8(4):ofab072. PMID: 33855102.Published on 3/24/2020
Asundi A, Stanislawski M, Mehta P, Mull HJ, Schweizer ML, Barón AE, Ho PM, Gupta K, Branch-Elliman W. Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program. Sci Rep. 2020 03 24; 10(1):5276. PMID: 32210289.Published on 1/30/2020
Mull HJ, Stolzmann K, Kalver E, Shin MH, Schweizer ML, Asundi A, Mehta P, Stanislawski M, Branch-Elliman W. Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the Veterans Health Administration's electronic medical record. BMC Med Inform Decis Mak. 2020 01 30; 20(1):15. PMID: 32000780.Published on 1/1/2020
Asundi A, Bhadelia N. Making Emergency Use of Experimental Vaccines Safer. AMA J Ethics. 2020 01 01; 22(1):E43-49. PMID: 31958390.Published on 9/18/2019
Asundi A, Cervantes-Arslanian AM, Lin NH, Barbosa F. Infectious Myelitis. Semin Neurol. 2019 08; 39(4):472-481. PMID: 31533188.Published on 8/15/2019
Asundi A, Robles Y, Starr T, Landay A, Kinslow J, Ladner J, White L, Plank RM, Melbourne K, Weisholtz D, Bennett M, Pan H, Stern E, Lin A, Kuritzkes DR, Lin NH. Immunological and Neurometabolite Changes Associated With Switch From Efavirenz to an Integrase Inhibitor. J Acquir Immune Defic Syndr. 2019 08 15; 81(5):585-593. PMID: 31045650.Published on 6/4/2019
Asundi A, Stanislawski M, Mehta P, Baron AE, Mull HJ, Ho PM, Zimetbaum PJ, Gupta K, Branch-Elliman W. Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program. Infect Control Hosp Epidemiol. 2019 08; 40(8):855-862. PMID: 31159895.Published on 2/1/2019
Asundi A, Beliavsky A, Liu XJ, Akaberi A, Schwarzer G, Bisoffi Z, Requena-Méndez A, Shrier I, Greenaway C. Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysis. Lancet Glob Health. 2019 02; 7(2):e236-e248. PMID: 30683241.Published on 9/1/2018
Asundi A, Stanislawski M, Mehta P, Barón AE, Gold H, Mull H, Ho PM, Gupta K, Branch-Elliman W. Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program. Infect Control Hosp Epidemiol. 2018 09; 39(9):1030-1036. PMID: 30226128.
Published on 10/27/2020View full list of 1 media mentions.